华北制药：小儿氨酚烷胺颗粒+石家庄本地儿童感冒药
事件挖掘
2022-11-14 13:50:52
华北制药 (600812) 回答 投资者： 公司生产的复方氨酚烷胺胶囊、小儿氨酚烷胺颗粒用于流感的预防和治疗。 (来自：上交所)
············································································································································································································································································································································································································································································
声明：文章观点来自网友，仅为作者个人研究意见，不代表韭研公社观点及立场，站内所有文章均不构成投资建议，请投资者注意风险，独立审慎决策。
S
以岭药业
S
华北制药
工分
7.88
转发
收藏
投诉
复制链接
分享到微信
有用 11
打赏作者
无用
真知无价，用钱说话
0个人打赏
同时转发
评论（4）
只看楼主
热度排序
最新发布
最新互动
- 1